NCT03199599

Brief Summary

Prospective validation of a prognostic model based on advanced PET/CT image analysis in non small cell lung cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 23, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 27, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2019

Completed
Last Updated

April 13, 2020

Status Verified

April 1, 2020

Enrollment Period

3 years

First QC Date

June 23, 2017

Last Update Submit

April 10, 2020

Conditions

Non Small Cell Lung Cancer

Keywords

PET/CTimage processingoutcome

Outcome Measures

Primary Outcomes (1)

  • validation of a multiparametric PET/CT prognostic model

    overall survival rate

    18 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

150 patients with Non small cell lung cancer undergoing initial staging FDG PET/CT

You may qualify if:

  • non small cell lung cancer
  • initial fluorodeoxygluoces (FDG) PET/CT before treatment

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Poitiers

Poitiers, France

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • MATHIEU HATT, PhD

    Institut National de la Santé Et de la Recherche Médicale, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2017

First Posted

June 27, 2017

Study Start

September 1, 2016

Primary Completion

August 31, 2019

Study Completion

August 31, 2019

Last Updated

April 13, 2020

Record last verified: 2020-04

Locations

FR(1)